Impact of comprehensive molecular testing to reduce antibiotic use in community-acquired pneumonia (RADICAP): a randomised, controlled, phase IV clinical trial protocol

• Gabriela Abelenda-Alonso,
• Alexander Rombauts,
• Yolanda Meije,
• Mercedes Clemente,
• Lucía Ortega,
• Carmen Ardanuy,
• Jordi Niubó,
• Ariadna Padullés,
• Sebastian Videla

Affiliations

Gabriela Abelenda-Alonso

Infectious Diseases, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain

Alexander Rombauts

Infectious Diseases, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain

Yolanda Meije

Infectious Diseases Unit–Department of Internal Medicine, Hospital de Barcelona, Barcelona, Catalunya, Spain

Mercedes Clemente

Infectious Diseases Unit–Department of Internal Medicine, Hospital de Barcelona, Barcelona, Catalunya, Spain

Lucía Ortega

Infectious Diseases Unit–Department of Internal Medicine, Hospital de Barcelona, Barcelona, Catalunya, Spain

Carmen Ardanuy

Department of Clinical Microbiology Unit, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain

Jordi Niubó

Department of Clinical Microbiology Unit, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain

Ariadna Padullés

Department of Farmacology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain

Sebastian Videla

Department of Clinical Farmacology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain